DAVID HANSEN on In Alzheimer’s, More TREM2 Is Good for You
COMMENT The findings of Ewers et al. provide a valuable advance for understanding how measurements of the biomarker CSF sTREM2 relate to the rate of disease progression around the early symptomatic stages of Alzheimer’s. What the data imply, as far as TREM2 and ...